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Abstract
Migrants and ethnic minorities in the UK have higher rates of tuberculosis
(TB) compared with the general population. Historically, much of the
disparity in incidence between UK-born and migrant populations has been
attributed to differential pathogen exposure, due to migration from
high-incidence regions and the transnational connections maintained with
TB endemic countries of birth or ethnic origin. However, focusing solely on
exposure fails to address the relatively high rates of progression to active
disease observed in some populations of latently infected individuals. A
range of factors that disproportionately affect migrants and ethnic
minorities, including genetic susceptibility, vitamin D deficiency and
co-morbidities such as diabetes mellitus and HIV, also increase
vulnerability to infection with   orMycobacterium tuberculosis (M.tb)
reactivation of latent infection. Furthermore, ethnic socio-economic
disparities and the experience of migration itself may contribute to
differences in TB incidence, as well as cultural and structural barriers to
accessing healthcare. In this review, we discuss both biological and
anthropological influences relating to risk of pathogen exposure,
vulnerability to infection or development of active disease, and access to
treatment for migrant and ethnic minorities in the UK.
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            Amendments from Version 1
The revised version of this manuscript incorporates alterations 
and additions as suggested by the reviewers. Most significantly, 
the Introduction has been extended so as to emphasise the 
importance of both biological and social factors in explaining the 
disparity of TB incidence between migrants and ethnic minorities 
in the UK compared with the general population. 
See referee reports
REVISED
Introduction
Tuberculosis (TB) is a bacterial disease caused by Mycobacterium 
tuberculosis (M.tb), which most commonly affects the lungs1. 
M.tb infection is acquired by inhalation of infectious par-
ticles released from close contacts2. While 10% of those 
infected develop active disease, the majority of individuals 
mount an effective immune response leading to successful 
containment of M.tb growth; a condition known as latent 
M.tb infection or LTBI3. Active TB disease results in systemic 
symptoms including fever, weakness and weight loss, as well as 
site-specific symptoms. For active pulmonary TB disease, the 
most common symptoms are persistent coughing (sometimes 
producing blood) and chest pain3. In 15–20% of active cases, 
and usually in those with immunosuppression, the infection 
spreads outside the lungs causing extrapulmonary TB. The 
symptoms of extrapulmonary TB vary considerably depending 
on the site of infection, which may include lymph nodes, pleura 
and osteoarticular areas4. Untreated, the 10-year case fatality 
rate of active disease is between 54 and 86% in HIV-negative 
individuals5. LTBI, which is asymptomatic, ordinarily has a 
5–10% lifetime risk of reactivation2. LTBI may be diagnosed 
through cutaneous tuberculin skin test (TST) or interferon-γ 
release assays (IGRA), while clinically suspected TB disease is 
evaluated through chest radiograph and diagnostic microbiology 
for acid-fast bacilli. Effective antibiotic treatment is available, 
but involves long and complex regimens. Furthermore, rates 
of multi-drug-resistant TB (MDR-TB) and extensively-drug- 
resistant TB (XDR-TB) are increasing6.
Globalisation, conflict and financial reasons have become 
increasingly important drivers of migration flows, leading to 
more permanent migrants moving from low/middle income 
to high-income countries7. Studies of the incidence of TB in 
migrant communities in several high-income countries including 
Western Europe, the United States and Australia provide 
important evidence of disparity between subpopulations8–12. In 
the UK, a substantial proportion of foreign-born migrants arrive 
from former colonies in sub-Saharan Africa and the Indian 
Subcontinent (ISC)13. Incidence of TB disease is higher 
among all migrant and ethnic minority groups living in the UK 
compared with the UK-born population. In 2016, 73.6% of 
individuals with diagnosed TB disease were foreign-born, with 
India and Pakistan the most frequent countries of birth among 
such cases14. While TB rates have been falling slowly across all 
UK populations since 2011, they remain 15 times higher in the 
foreign-born than the UK-born population. Furthermore, within 
the UK-born population, non-white ethnic groups had TB rates 
3 to 14 times higher than the white ethnic group14. There is much 
heterogeneity in both absolute number of cases and incidence 
rates (per 100,000 of population group) among migrants from 
different countries and among different ethnic groups. While 
number of cases is confounded by size of population group, 
variation in incidence rate reflects varying levels of risk for 
different migrant and ethnic groups. Migrants from the ISC 
(India, Pakistan and Bangladesh) and black ethnic groups 
demonstrate particularly high incidence15.
In explaining this disparity, the media have claimed that migrants 
and ethnic minorities ‘import’ TB into the UK. For example, 
according to the Daily Express, a TB outbreak in Leicester in 
2001 indicated that “we are still vulnerable to infection from 
other countries” because “immigrants and visitors from less 
medically-advanced countries can carry the infection into 
Britain”16. In this way, migrants and ethnic minorities are 
labelled as carriers of infectious agents17. This popular view 
attributes the disparity in TB rates solely to differential pathogen 
exposure. Although exposure to M.tb in country of origin plays 
an important role, such an attitude obscures the mix of factors 
that increase the vulnerability of migrants and ethnic minorities 
to development of active TB disease from latent infection, and 
the influence of differential treatment-seeking behaviour in 
promoting the spread and therefore incidence of TB within 
these communities. As King highlights, TB is a complex 
disease and “the disproportionate burden of TB on certain 
populations is seldom the result of a single obvious cause”18. 
In particular, it is difficult to disentangle socio-economic dis-
advantage from migrant/ethnic cultural identity in analyses of 
how reactivation of latent infection as well as transmission 
contribute towards TB incidence in migrant and ethnic 
minority populations; especially given that their relative impor-
tance differs between and within these groups. Nevertheless, it is 
clear that each factor - from the biological to the social19 - has a 
role to play and should be considered in strategies to tackle 
this inequality.
We discuss the biological, social and cultural factors relating 
to risk of pathogen exposure, vulnerability to infection or 
development of active disease, and access to treatment which 
contribute to the increased incidence of TB in migrant and 
ethnic minorities in the UK (Figure 1).
Epidemiology
The higher burden of TB observed among foreign-born 
individuals in the UK could be due to arrival of migrants 
with active TB, reactivation of remotely-acquired LTBI 
post-arrival, or local transmission20. Meta-analyses of screens for 
active TB at entry have indicated that only a small proportion 
(~0.35%) of immigrants have active TB at time of arrival in the 
EU/EEA21,22. Since 2012, the UK Home Office has required 
pre-arrival screening for active pulmonary TB disease for all 
long-term visa applicants from endemic countries; those diag-
nosed with active disease are denied a medical clearance 
certificate23. Thus arrival of migrants with active TB is not 
thought to contribute significantly to the overall burden of 
disease among foreign-born individuals in the UK; rather several 
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Figure 1. Summary of factors contributing to the increased incidence of TB in migrant and ethnic minorities in the UK.
studies suggest a more prominent role for the reactivation 
of remotely-acquired LTBI post-arrival20,24,25. In the initial 
years following arrival in a lower incidence setting, migrants 
with LTBI have a higher risk of reactivation than the host 
population8,26,27.
Local transmission within immigrant communities in the UK 
may also contribute to the higher incidence of TB cases observed 
in migrants and ethnic minorities. Such groups are more likely 
to live in densely-populated areas with a high concentra-
tion of their ethnic community, which may foster spread of TB, 
particularly given the mode of transmission28. Moreover, Bakhshi 
suggests that larger household size among migrants and ethnic 
minorities - perhaps due to cultural factors favouring a 
multi-generational rather than nuclear family structure - increases 
M.tb transmission, as approximately one-third of household 
contacts will become infected in a household with an active TB 
case29.
In order to establish the relative importance of local transmis-
sion versus reactivation of LTBI, molecular fingerprinting 
and other strain typing have been used since the 1990s. Genetic 
clusters have been assumed to represent epidemiologically 
linked chains of recent transmission, whereas unique isolates 
have been taken to represent reactivational disease30. Early 
findings were conflicting, likely due to the inability of such 
techniques to reliably distinguish past and recent transmission31. 
The advent of whole-genome sequencing of M.tb offered 
additional resolution, and in one such study of Oxfordshire 
TB cases in 2007–2012, those born in a high-incidence country 
were less likely to be part of a recent transmission cluster than 
those born in a low-incidence country (especially the UK), even 
when adjusting for social risk factors32. Similarly, Aldridge 
et al. identified only 35 of over 300,000 migrants screened prior 
to entry into England, Wales and Northern Ireland as assumed 
index cases for transmission clusters33. In addition, a Canadian 
study found no evidence to support concerns about transmission 
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from immigrants born in high-incidence countries. These 
findings suggest that reactivation of LTBI is more important 
in explaining the higher incidence of TB among migrants than 
exogenous infection due to local transmission.
Differential exposure
Rates of active TB disease diagnosed after arrival in the UK 
correlate with TB incidence in the country of origin34, indicat-
ing that differential exposure among migrants is a key factor 
influencing TB incidence in foreign-born populations. 13% of 
foreign nationals in the UK are from a country where TB 
incidence is ≥250 cases per 100,00013. After the Second World 
War, substantial numbers of migrants arrived from the 
Commonwealth and former British Empire; particularly from 
the ISC. These movements were driven by factors such as 
Britain’s labour shortages for post-war reconstruction and 
political turbulence after decolonisation, for example following 
the creation of Pakistan35. Many Commonwealth countries have 
high TB incidences: the highest incidences globally are found 
in Africa (275 per 100,000 population in 2015) and South East 
Asia (246 per 100,000)6. Migrants from these countries are at 
a greater risk of having been exposed to M.tb and contracting 
LTBI. Indeed, of the 11 countries that were each the source of 
more than 2% of foreign-born cases in 2001–2003 (collectively 
accounting for 73% of foreign-born cases), all were in South Asia 
or sub-Saharan Africa36.
It is useful to consider migration to the UK from the 
perspective of transnationalism, defined as “the process by which 
immigrants forge and sustain multi-stranded social relations 
that link together their societies of origin and settlement”37. 
From the 1920s until recently, migration research has tended 
to focus on the incorporation of migrants in their destination 
country rather than continued ties with their country of 
origin. However, since the 1990s, “the transnational turn” has 
provided “a new analytic optic”38. From this perspective, given 
that migrants maintain ties across the borders of nation-states, 
return visits to their country of origin and overseas visitors to 
the UK may result in increased exposure to M.tb. Where data 
was available, 17.2% of TB cases in 2016 in England had 
travelled outside the UK (excluding Western Europe, US, 
Canada, New Zealand and Australia) in the two years before 
diagnosis, and 7.3% had received an overseas visitor. 23.3% of 
non-UK born cases had travelled outside the UK in 2016 
compared with only 4.7% of UK born cases14. Such movements 
are increasing as globalisation leads to the intensification of 
international interconnectedness: in the UK, travel to visit 
family and friends abroad increased by 67% between 1998 and 
200739. In 2007, UK residents made nearly 900,000 trips to the 
ISC for the purpose of visiting friends and family39.
There is some evidence to suggest that travel to countries with 
high TB incidence increases the risk of acquiring LTBI, with 
greater risk associated with more prolonged travel and higher TB 
burden in the destination country40. Such individuals are then at 
risk of developing active disease after returning to the UK. A 
study in Blackburn, Hyndburn and Ribble Valley found that 
12.8% of active cases among Indian, Pakistani and Bangladeshi 
ethnic groups occurred within 3 years of revisiting the ISC41. 
Furthermore, a case-control study in Liverpool found that TB 
cases were 7.4 times more likely to have recently received 
visitors from abroad42. A case-control study of patients of ISC 
ethnic origin in North West England found a weak associa-
tion between revisiting the ISC and TB cases within the follow-
ing 3 years43. However, there is currently limited data in this 
area and further research is needed to determine the proportion 
of TB acquired through travel20. In particular, there is a need to 
elucidate whether certain types of travel are associated with a 
greater risk of acquiring LTBI, for example health professionals or 
volunteers44.
Second generation immigrants (born in the UK but with parents 
born overseas) are at lower risk of TB than first generation 
immigrants (born overseas and migrated to the UK) but still 
remain at increased risk compared with the general population15. 
This suggests a role for exposure to M.tb in the country of 
origin, but the higher incidence of TB among ethnic minorities 
compared with the general population is likely to be partially 
attributable to transnational connections, transmission within 
migrant populations, and other factors discussed in this review. 
However, quantification of the TB burden in this group is 
challenging as second generation migration is insufficiently 
captured by the prevailing European surveillance variables, 
and prospective studies on the risk of TB in successive migrant 
generations are lacking45.
A further dimension of differential exposure is variation in 
pathogen factors such as global genomic diversity in the M.tb 
complex. There are six major genetic lineages of M.tb found in 
distinct geographical regions46. Lineages can induce different 
host immune responses47–49, and it is possible that M.tb strain 
may contribute to variation in clinical TB phenotype between 
ethnic groups, for example the higher prevalence of extrapul-
monary disease among non-white ethnic than UK-born cases50. 
However, a study in an ethnically heterogeneous UK population 
found that ethnicity was strongly associated with clinical 
TB phenotype independent of M.tb lineage, suggesting that 
host factors may be more important in determining the clinical 
manifestation of TB51.
BCG vaccination
Mycobacterium bovis Bacille Calmette-Guerin (BCG) is the only 
currently available vaccine against TB. BCG confers reliable 
protection against disseminated forms of TB such as miliary 
disease and meningitis in infants52,53. However, protection 
against pulmonary TB (the most common form of disease) varies 
considerably by geographical region54. While the UK has one 
of the highest levels of BCG efficacy (~80%), a low level, or 
complete lack of, protection has been reported in many 
migrant countries of origin such as India54–56. The problem may 
be further confounded by limited access to vaccines and other 
healthcare in low-income country settings, but prevalence of 
M.tb infection in endemic countries remains high even where 
there is good BCG coverage57,58.
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It has been hypothesised that exposure to non-tuberculous 
environmental mycobacteria (NTM), which increases with 
proximity to the equator, plays a central role in limiting BCG 
efficacy59. Individuals may develop an immune response to 
NTM that either ‘masks’ or ‘blocks’ the ability of BCG to 
induce a protective response59–62. In a trial in Chingleput, India, 
95% of individuals were PPD positive by 15–20 years of 
age63. In a trial in Malawi where there is high NTM exposure and 
poor BCG efficacy, individuals with lower immune responses to 
NTM showed greater IFN-γ responses to BCG64. Furthermore, 
in mice sensitised with NTMs, the protective effect of BCG 
(but not a TB subunit vaccine) was considerably reduced65. The 
low levels of BCG protection found in countries with high TB 
incidence likely contribute to the prevalence of LTBI among 
migrant populations.
Genetic susceptibility
The idea of a heritable component to TB was suggested as 
early as 1886 by Hirsch: “That phthisis [TB] propagates itself in 
many families from generation to generation is so much a matter 
of daily experience, that the severest sceptic [sic] can hardly 
venture to deny a hereditary element in the case”66. There are 
several lines of evidence suggesting that host genetic factors 
may contribute to TB susceptibility and resistance67. Early 
studies demonstrated that monozygotic twins have a higher risk 
of developing active TB compared with dizygotic twins68,69, and 
several relevant loci have since been identified using candidate 
gene studies and genome-wide association studies70–75. Variation 
in susceptibility to M.tb infection and progression to active 
disease has been observed in different ethnic and geographic 
populations76,77. A study of >25,000 residents in racially- 
integrated nursing homes in Arkansas, USA, found that 13.8% of 
African-American compared with 7.2% of Caucasian residents 
had evidence of a new M.tb infection78. Furthermore, in a study 
of three TB outbreaks in two prisons, African-Americans had 
approximately twice the relative risk compared with Caucasians 
of becoming infected with M.tb78. However, although these 
studies largely controlled for environmental factors, confounders 
such as differing vitamin D levels cannot be ruled out.
More recently, genotyping technologies have supported a role 
for genetic ancestry in TB susceptibility. A case-control study 
genotyped a panel of ancestry informative markers to estimate 
the ancestry proportions in a South African Coloured [sic] 
population. African ancestry (particularly San ancestry) was 
higher in TB cases than controls, and European and Asian 
ancestries were lower in TB cases than controls76. However, a 
limitation is that the study did not adjust for socioeconomic 
confounders. Differences in alleles that encode components of 
the immune response provide a possible mechanism for ethnic 
variation in TB susceptibility. Indeed, a study of African and 
Eurasian pulmonary TB patients in London indicated ethnic 
differences in the host inflammatory profile at presentation 
including lower neutrophil counts, lower serum concentrations 
of CCL2, CCL11 and DBP, and higher serum concentrations of 
CCL5 in those of African ancestry79. These differences became 
more marked following initiation of antimicrobial therapy, 
and were associated with ethnic variation in host genotype but 
not M.tb strain79.
Attributing variation in TB incidence between populations 
to genetic differences has been criticised, particularly due to 
fears that a discussion of ‘innate’ differences will perpetuate the 
naturalisation of inequalities in TB incidence80. Moreover, ‘race’ 
is a problematic concept, acting only as a proxy for genetic vari-
ation that is continuously distributed according to ancestry81. 
However, to recognise that there is some genetic variation in TB 
susceptibility that broadly aligns with ethnic groups is not to 
deny that there are other factors contributing to differences in TB 
incidence, as discussed in this review.
Host-pathogen co-evolution is a likely driver of variation in TB 
susceptibility in different human populations82. M.tb has been 
co-evolving with humans for millennia, with evidence that 
humans were exposed before the Neolithic transition83. The 
differential susceptibility of particular populations may be based 
on M.tb exposure history, with long-term exposure resulting in 
strong positive selection for resistance-related alleles. There is 
evidence from European colonialism that previously underex-
posed populations are more susceptible to TB, which played 
a large part in the deaths of many Qu’Appelle Indian and Inuit 
populations in Canada84,85. Similarly, in contrast to Europeans, 
Southern African populations have only been exposed to modern 
M.tb strains relatively recently76. It has been suggested that 
selection pressure for resistance would have been strongest in 
areas of high population density. Accordingly, duration of 
urban settlement is correlated with the frequency of the SLC11A1 
1729 + 55del4 allele which plays a role in natural resistance 
to intracellular pathogens including M.tb86. Lower rates of TB 
among those of European ancestry could be due to centuries 
of exposure in densely populated settlements driving the 
evolution of increased resistance.
Vitamin D deficiency
It has long been recognised that low vitamin D levels are 
associated with active TB, with sunlight exposure in sanato-
ria and direct administration of vitamin D commonly used as 
treatments prior to the advent of antibiotics87. Today, evidence 
supporting a link between TB and vitamin D deficiency is 
accumulating, although the association is complex88–91. A 
meta-analysis indicated a 70% probability that, when chosen at 
random from a population, an individual with TB disease would 
have a lower serum vitamin D level than a healthy individual92, 
although the direction of causality is not clear. It has been 
demonstrated that 1,25(OH)2D, the active metabolite of 
vitamin D, promotes the ability of macrophages to phagocytose 
M.tb and enhances the production of cathelicidin LL-37, an 
antimicrobial peptide that has direct bactericidal activity and 
attracts other immune cells to the site of infection93. There 
is evidence that a drop in serum vitamin D compromises the 
immune response and can lead to reactivation of LTBI94. 
Vitamin D deficiency may also be a risk factor for extrapul-
monary dissemination of TB, which is more common among 
migrants and those of non-white ethnic groups95,96.
Vitamin D can be acquired from the diet or endogenously 
synthesised in the skin by the photolytic action of solar UV 
light on the precursor molecule 7-dehydrocholesterol97,98. 
Certain migrant and ethnic minority groups are at a greater risk 
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of vitamin D deficiency99–101. Indeed, vitamin D levels have 
been shown to be lower among Asian children living in 
England compared with children of the same age in the general 
population102. Vegetarians are at increased risk of vitamin D 
deficiency since oily fish are a major dietary source103, and 
Hindu Asians are more frequently vegetarian than the general 
population due to socio-religious factors104. A study of Asian 
immigrants with TB disease in Wandsworth found that Hindus 
were at higher risk of contracting TB than Muslims105. Darker 
skin pigmentation also increases risk of deficiency, as 
melanin reduces the efficiency of vitamin D synthesis from 
UVR101,106. Hindu women in particular have been found to 
be at high risk, as in a 1976 study by Hunt et al. they spent on 
average only 2.5 hours a week outside for cultural reasons, 
whereas men were exposed to sunlight travelling to work107.
1,25(OH)2D mediates its immune activity through binding to 
the vitamin D receptor (VDR) on target cells; thus receptor 
abnormalities as well as vitamin D deficiencies may impair host 
immunity to M.tb108. Some polymorphisms in the VDR gene 
increase susceptibility to TB, while others increase resistance109,110. 
In a systematic review of seven studies comparing the 
prevalence of VDR polymorphisms in TB patients and 
healthy controls, BsmI and FokI VDR polymorphisms 
were found to increase TB susceptibility111. The VDR gene 
shows striking genetic variation in allele frequency between 
populations112. Moreover, certain polymorphisms play differ-
ent roles in different populations111, although further research 
is required to elucidate how this translates into variation in 
patterns of susceptibility and resistance to TB in different 
ethnic groups. Epigenetic variation in the VDR gene in different 
ethnic groups, arising from differential exposure to environmental 
factors, may influence gene regulation and therefore contribute 
to differential TB susceptibility. Indeed, methylation variable 
positions at the 3’ end of VDR have been identified that are 
significantly correlated with ethnicity and TB status113.
Co-morbidities
Risk of progression to active TB disease is increased in those 
with conditions that impair immunity, such as diabetes mellitus 
(DM), human immunodeficiency virus (HIV) and chronic kidney 
disease (CKD)114. Certain migrant and ethnic groups are at a 
higher risk of these conditions; diabetes mellitus disproportion-
ately affects South Asians whereas HIV is more prevalent among 
those of African origin, and chronic kidney disease affects both 
groups.
a) Diabetes mellitus
Clinicians have noted a possible association between TB and 
DM since the early 20th century115. More recently, a meta- 
analysis of 13 cohort studies found that DM increases the risk 
of active TB 3.11-fold116. A causal relationship between DM and 
impaired immunity to TB is supported by studies of diabetic 
mice, which have higher bacterial loads when infected with 
M.tb than non-diabetic mice117. DM-TB comorbidity increases 
both the risk of new and reactivational TB118, although 
diabetes as an independent risk factor was associated with only 
a modest overall increased risk of TB in a UK General Practice 
cohort119. Various mechanisms have been suggested including 
impaired immune function due to DM, complications of DM, 
and deficiencies in vitamins A, C and D associated with both 
TB and DM risk120.
Type 2 DM (T2DM) and associated risk factors, especially 
obesity, show marked associations with ethnicity121. In the UK, 
obesity and T2DM risk is significantly higher among South 
Asians (including those of ISC origin), and moderately 
higher among black African-Caribbeans compared with white 
Europeans122. The prevalence of DM among South Asians in 
England was 14% in 2010; approximately double the 6.9% 
prevalence in the general population123. Some studies have 
suggested that ethnic differences in T2DM can be explained 
by differences in socio-economic status124, while others do not 
support this121. It is clear there are complex genetic and envi-
ronmental explanations for ethnic differences in T2DM preva-
lence, which are beyond the scope of this review (for example, 
see 125).
b) Human immunodeficiency virus
Infection with HIV is the strongest known risk factor for the 
development of TB disease126. TB-HIV co-infection synergis-
tically worsens both conditions, leading it to be termed ‘the 
cursed duet’127. HIV increases both the risk of rapid progression 
to active disease following infection and reactivation of LTBI, 
with an increased risk of TB throughout the course of HIV-1 
disease128,129 and incidence rate ratios >5 when averaged across 
all levels of immunodeficiency130. The depletion of CD4+ 
T cells associated with HIV-1 infection is thought to play a 
major role in the increased risk of TB and its extra-pulmonary 
dissemination in infected individuals, as M.tb infected macro-
phages require CD4+ T cells to augment intracellular clearance131. 
Furthermore, peripheral blood lymphocytes of HIV-positive 
patients produce less interferon-γ when exposed to M.tb in vitro 
than those of HIV-negative patients132. These and other possible 
immune mechanisms such as chronic inflammation promoting 
an immunoregulatory phenotype and attenuation of phagocytosis 
have been recently reviewed133.
A systematic review on the prevalence, incidence and mortality 
of HIV-TB co-infection in Europe observed a disproportionate 
vulnerability of migrants to co-infection across studies134. 
Given that only 3.8% of TB cases in England in 2015 involved 
co-infection with HIV14, TB-HIV co-infection cannot be 
considered a major driver of higher TB incidence among migrants 
and ethnic minorities in the UK; although this group repre-
sents an important target in the prevention of M.tb infection and 
progression to active disease. TB-HIV coinfection undoubtedly 
plays a role in explaining the higher TB incidence rates among 
those of African origin. In 2015, 81.8% of TB-HIV co-infected 
cases in England were foreign-born, of which 68.7% were born 
in sub-Saharan Africa14 This reflects the global distribution of 
TB-HIV co-infection. In the WHO African region, 38% of new 
TB cases were co-infected130. In turn, the global pattern of 
TB-HIV co-infection reflects the global distribution of HIV: 
69.5% of all people living with HIV are in the WHO African 
region135.
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c) Chronic kidney disease
The association between CKD and TB was first reported in 
1974136, and has been subsequently confirmed by several 
studies137–139. The mechanism is thought to be impaired immu-
nity: CKD is associated with functional abnormalities in various 
immune cells, such as B and T cells, monocytes, neutrophils, 
and natural killer cells140. This increases the risk of both newly 
acquired and reactivated TB. Furthermore, immunosuppres-
sive medications in kidney transplant patients are aimed at 
T cell-mediated immunity, which is central to maintaining 
TB latency in LTBI individuals141. Patients with CKD are 
10–25 times more likely to develop active TB142.
Ethnic minorities in the UK are at a 3–5 times higher risk of 
developing CKD143. A study in London from 1994–1997 found 
that the incidence rate among white Caucasians was 58/million 
adult population per year, 221 among South Asians, and 
163 among African-Caribbeans144. More recently, in a study of 
CKD patients with TB in South East London, 74% were born 
outside of the UK145. CKD also interacts with other risk factors 
that contribute to higher incidence of TB among migrants and 
ethnic minorities. DM patients are 4–5 times more likely to have 
CKD146, CKD patients are more likely to have low vitamin D 
levels147, and CKD is a complication associated with HIV148. 
Furthermore, CKD disproportionately affects economically 
disadvantaged groups, possibly due to the direct impact of 
poverty or malnutrition, or indirect effects of poverty- 
associated co-morbidities including DM and HIV149. Given 
the complex interactions between multiple risk factors, it is 
difficult to establish the direction of causality.
Socio-economic status
The association between deprivation and TB has long been 
recognised, leading it to be dubbed a “social disease”150 and 
“poverty’s penalty”151. There is a strong socio-economic gradient 
in TB burden between and within countries and communities, 
with economically disadvantaged groups having the highest 
risk152. The importance of social factors in TB risk is supported 
by McKeown’s observation that a considerable proportion of the 
decline in TB-associated mortality occurred before the advent 
of antibiotics and the BCG vaccine, implicating improved 
living standards and nutrition as the main drivers153. Szreter 
contests the McKeown thesis, emphasising the key role of 
public health measures in regulating the urban environment154. 
Either way, it is clear that TB disproportionately affects the 
socially and economically marginalised, with a recognised role 
for poverty, homelessness, and overcrowding in both the spread 
of infection and number of active cases18. In the UK in 2009, TB 
cases among the homeless were 20 times higher than the 
general population at 300 cases per 100,000155. In a study of 
London districts, the TB notification rate increased by 12% for 
every 1% rise in the number of people living in overcrowded 
conditions156.
The wider social determinants of health are entwined with 
ethnicity, meaning that ethnic socio-economic disparities 
throughout the life course often lead to health inequalities157. 
There are marked economic inequalities between ethnic groups 
in the UK, with both Asian and black ethnic groups having 
lower employment probability than the population average158. 
Alongside economic issues of unemployment, low income and 
poor working conditions, migrants and ethnic minorities 
are also more likely to face problems of homelessness, poor 
housing, and overcrowding159. Foreign nationals accounted for 
13% of the general UK population in 2015160, but 20% of the 
homeless population161. In 2011, dwellings with a Household 
Reference Person (HRP) from a minority ethnic group rep-
resented 16.1% of all households in England and Wales, but 
47.9% of overcrowded households. The most commonly 
overcrowded households were those with a Bangladeshi HRP 
(30.2% overcrowded), followed by Pakistani (22.3%) and 
black-African (21.8%)162.
King rejects what he terms ‘essentialist’ explanations for the 
higher TB incidence of migrants and ethnic minorities, which 
claim that TB disproportionately affects certain groups due to 
intrinsic differences, which may be biological, genetic, physi-
ological or cultural. Instead he suggests that “Disparities in 
health that may at first seem to arise from essential racial or 
ethnic differences are often in fact the result of contingent 
socioeconomic differences”18. Similarly, Farmer rejects psycho-
logical or cultural explanations, emphasising that “tuberculo-
sis is inextricably tied to poverty and inequality”. He criticises 
studies that neglect to address the political-economic forces 
that shape TB distribution, and calls for anthropologists to pay 
more attention to structural violence (the systematic ways in 
which social structures disadvantage individuals) and social 
inequality163.
King and Farmer claim that, given that socio-economic status 
affects TB risk, biological and genetic approaches are largely 
irrelevant18,163. Similarly, the medical anthropologist Singer 
criticised the use of adaptation as a conceptual tool on the basis 
that such explanations ignore how the political economy shapes 
the environment that humans adapt to. She argues that differential 
mortality between socio-economic groups is “unnaturally 
selected” by the conditions created to further the interests of 
the dominant class164. However, as discussed, there is evidence 
to suggest that adaptation resulting from host-pathogen 
co-evolution influences direct and indirect genetic susceptibil-
ity to TB infection and progression to active disease. Perhaps as 
Mason et al. suggest, a more constructive approach is required, 
recognising that “the social model is an important complement 
to the biomedical model”165.
Given the complex association between ethnicity and socio- 
economic status, it is hard to disentangle the extent to which 
socio-economic disadvantage influences TB incidence in migrant 
and ethnic minority populations166. One study in children from 
Leeds found that overall, ethnicity explained a high proportion 
of TB incidence independently of deprivation and population 
density, although for non-South Asian children, the strongest 
risk factor was deprivation167. Similarly, a study in Liverpool 
suggested an association between ethnicity and TB incidence 
that was independent of deprivation level168, and a study investi-
gating TB trends in England in 1999–2003 indicated that affluent 
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ethnic minority groups are still at greater risk166. It has been 
suggested that the absence of a strong correlation between dep-
rivation and M.tb infection in the South Asian community 
may be due to the smaller relative differences in deprivation 
within this group than across the general population169. Indeed, 
a study in Newham found an association between the propor-
tion of non-white residents and TB diagnosis in each ward, but 
no association with deprivation as the borough as a whole was 
deprived170.
There is significant heterogeneity in the role that social risk 
factors play in increasing TB risk in different migrant and 
ethnic groups. Among UK-born cases notified in 2010–2016, 
33.1 % of those in the black-Caribbean ethnic group had at least 
one social risk factor (homelessness, imprisonment, drug or 
alcohol misuse), higher than any other ethnic group14. 19.4 % of 
black-Caribbean cases were drug users, and 18.6% had a his-
tory of imprisonment. The countries of origin with the highest 
number of homeless TB cases were Somalia, at 95 cases, 
and Eritrea, at 91 cases14. This suggests that socio-economic 
disadvantage may play a particularly important role in explain-
ing higher TB incidence among the black-African and black- 
Caribbean ethnic groups.
Experiences of migration
The difficulties faced during and shortly after migration may 
increase risk of progression to active disease by compromis-
ing immunity, including poor nutrition, concurrent poor health, 
socioeconomic marginalisation, and the stress of relocation18. 
In an anthropological study of illegal Chinese immigrants with 
TB in New York, it was found that migrants often experience 
shortages of food and water during long migratory journeys. 
Upon arrival, temporary residence in detention centres or illegal 
refuges is associated with overcrowding and malnutrition171. 
Migrants then face additional challenges including loss of a 
social support network, communication issues, discrimination, 
and acculturation172. Ho calls for a focus on the macro-level 
structural forces that shape TB risk on migratory journeys, such 
as a lack of government regulation and exploitation by human 
traffickers171.
Psychological effects include higher rates of anxiety among 
refugees and asylum seekers compared with the general popu-
lation or other migrant groups173, and poorer mental health in 
forced compared with voluntary migrants174. Furthermore, 
Africans in Britain are at a higher risk of mental illness than 
non-Africans175, and survey data suggests that immigration is 
a primary cause of mental distress in about 40% of Africans 
in the UK176. It has been suggested that the psychological stress 
and depression associated with migration may play a role in 
increasing risk of progression to active disease, potentially via 
neuroendocrine pathways or a negative effect on the cell- 
mediated immune system177.
Importantly, rather than transporting active cases of TB across 
national borders, the majority of immigrant cases of active TB 
disease develop following arrival in the UK20. This supports 
King’s assertion that “The higher rate of TB among immigrants 
owes as much to the hardships they face during and shortly 
after migration, as it does to their country of origin”18. Further 
research is required to establish the extent to which stress and 
adverse migratory journeys affect specific migrant groups. 
However, experiences of migration are likely to contribute 
at least in part to the higher rates of active TB among migrants 
compared with UK-born ethnic minorities and the general 
population, especially for those who are marginalised or are 
travelling illegally.
Treatment-seeking
Knowledge about TB among migrants and ethnic minorities is 
shaped by cultural beliefs, often arising from experiences in the 
country of origin178. Certain ideas, including misconceptions 
about TB causation, transmission and risk, can act as barriers to 
clinical treatment. Gerrish et al. suggest that “TB is not just 
a medical disease to be treated with antibiotic therapy but an 
entity with historical and cultural roots”179. Several studies 
have identified widespread misconceptions about TB causation 
and transmission among migrant communities, and a limited 
understanding of LTBI in particular172. The disease has been vari-
ously attributed to climate conditions180, poisoning, pneumonia181, 
exposure to chemical products182, and witchcraft183. Several 
members of a focus group of Somali women believed TB to be 
a punishment for past ill deeds178.
Migrants may feel a false sense of having ‘left behind’ the 
high risk of TB in their country of origin172, and TB may be 
considered by migrants to be a different, more severe, disease 
in their country of origin184. In some cases, TB may be thought 
of as incurable due to poor health services in low-income 
countries185. Moreover, immigrants may favour traditional sys-
tems of care and healing over Western medicine upon arrival186, 
making them more likely to turn to traditional folk healers, 
self-diagnosis or self-medication before accessing public 
healthcare facilities159. Cultural beliefs that lead to delays in 
treatment-seeking and reduced adherence to treatment may 
increase the risk of TB transmission within such communities.
Conversely, some have suggested that the cultural beliefs held 
by migrants are not barriers to treatment-seeking, but rather 
promote such behaviour. The higher prevalence of TB in 
migrants’ countries of origin could lead to greater awareness; 
as Bakhshi argues, “people born in developing countries are too 
familiar with the disease to neglect it”29. Moreover, Ho describes 
how traditional Chinese medical beliefs are often complemen-
tary to clinical TB treatment in New York, such as through the 
use of traditional Chinese medicine to reduce the side effects of 
anti-TB drugs171.
TB-related stigmatisation of immigrants has been reported in 
multiple studies (reviewed in 172). Stigma is defined as “the 
situation of the individual who is disqualified from full social 
acceptance”, and is therefore “reduced in our minds from a whole 
and usual person to a tainted, discounted one”187. Some cul-
tures consider TB to be sinful and dirty178. The feelings of guilt 
and shame188 and risk of rejection and discrimination189 that 
may result from stigmatisation affect attitudes towards diagnosis, 
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treatment and prevention, and therefore hinder control of TB 
and facilitate its transmission within certain migrant and ethnic 
groups190. Sufferers may hide their illness to avoid stigma and 
discrimination and protect personal or family dignity183. One 
study indicated that stigma prevented some immigrants from 
sharing information with their doctors, even TB-related 
symptoms191. Furthermore, patients may be less likely to iden-
tify contacts due to concerns about social repercussions, 
meaning that subsequent preventable TB cases may occur179. 
Feelings of stigma produced by attitudes in the country of origin 
are likely to be exacerbated by the negative stereotyping of 
migrant groups as ‘dirty’ or ‘diseased’ due to the associa-
tion of TB with immigrants, which may lead to xenophobia and 
discrimination of sufferers185, termed ‘sociomedical racism’ 
by McBride (1991)192.
The Somali community in the UK provides an informative case 
study of the socio-cultural meaning and perceived consequences 
of TB. In Somalia, TB is associated with extreme stigma and 
social isolation. In a focused ethnography of Somali-born UK 
residents, Gerrish et al. found that interviewees tended to base 
their attitudes towards TB on those prevalent in Somalia179. 
The stigma associated with TB led to expectations of social 
isolation, shame and loss of self-worth, sometimes extending 
to the whole family. Although most had an understanding that 
TB is contagious, it was also commonly believed that people 
remain infectious after treatment, as TB was often thought to 
be hereditary and therefore impossible to eradicate. This led to 
fears that friends would not resume normal social interactions 
after treatment, and that a diagnosis would jeopardise marriage 
prospects. Therefore, sufferers tended to isolate themselves or 
conceal their illness. In reality, anticipated consequences tended 
to be worse than actual experiences of discrimination, but felt 
stigma was nonetheless a powerful deterrent to disclosing 
illness, leading to delays in diagnosis and treatment179.
Access to healthcare
Migrants may have difficulties establishing ‘entitlement’ to good 
healthcare193. For example, a study in the UK found that only 
32.5% of new migrants who were instructed to register with 
a GP had done so, and the migrant groups with the smallest 
proportion registered were likely to have greatest need194. This 
is consistent with the Inverse Care Law, that those with the 
greatest need are least able to access healthcare services195. 
Various studies have found that migrants face barriers in access-
ing healthcare services for TB diagnosis or treatment. These 
include lack of awareness of the local health system, includ-
ing availability of free services196, language barriers197, and fears 
about loss of privacy due to the use of interpreters184. Therefore, 
even in cases where there are minimal geographic or economic 
barriers to accessing health facilities, there are often racial, 
linguistic and cultural barriers to using these facilities effectively 
and adhering to treatment regimens198. Worryingly, institutional 
racism within the NHS may pose a further barrier to healthcare 
access for both migrants and ethnic minorities. There is evidence 
that, when commissioning services, Trusts often fail to meet 
the needs of black and ethnic minority populations, which may 
reflect a lack of diversity among the NHS senior workforce199–201.
Studies have found that migrants face various structural barriers 
to accessing healthcare services, such as transport difficulties 
associated with poor services in deprived areas178, and rigid 
opening hours for medication that do not fit with the working 
hours and lifestyles of patients202. Moreover, economic barriers 
include not only direct costs associated with illness, such as 
the costs of repeated journeys to clinics for treatment, but 
also indirect costs including losing a job or being evicted by a 
landlord203. Farmer criticises anthropological investigations for 
conflating structural violence with cultural difference, tending 
to exaggerate the role of patient agency and minimise the 
role of poverty and the barriers that it creates to accessing 
adequate care and completing treatment163. Nevertheless, whether 
structural or cultural, barriers to healthcare access among migrant 
and ethnic groups can lead to delays in diagnosis and treatment, 
resulting in increased transmission and incidence.
Access to healthcare services varies across different migrant 
populations. Although treatment of TB is free for all in the 
UK, refugees and asylum seekers have poorer access to health 
services204. Irregular residence status is likely to lead to sig-
nificant delays in seeking medical assistance, due to uncertain-
ties surrounding entitlement to services and fears of deportation, 
since TB patients can be legally deported while receiving 
ongoing treatment205. Furthermore, irregular migrants may face 
difficulties in completing long-term TB treatment, which 
involves repeated consultations, if they do not have housing or 
employment and are short-term residents. Irregular migrants 
are also less likely to be willing to provide details of their 
migratory route184 and provide information about contacts183. 
Contact tracing is further compromised given the high mobility 
of migrants, and the fact that many do not reside at their 
official address, but with family and friends184.
Conversely, there is evidence to suggest that UK-born cases 
experience longer delays from symptom onset to commence-
ment of treatment than foreign-born cases15. Moreover, TB 
treatment completion is actually marginally higher in migrants 
(85%) than the UK-born (81%)50. However, these observa-
tions are problematic in that UK-born TB cases are often drawn 
from homeless individuals, problem drug users and prisoners, 
and so are frequently lost to follow-up and poorly adherent206; 
they are not representative of the UK-born population as a 
whole. Furthermore, migrants are at a higher risk of contracting 
TB due to the various unique factors discussed (including 
genetics, vitamin D deficiency, co-morbidities, and experiences 
of migration), which do not apply to the UK-born, making 
socio-economic issues the key driver of TB incidence in this 
group. Indeed, in 2016, 2.4 times as many UK-born cases 
(20%) as foreign-born cases (8.2%) had at least one social 
risk factor (drug misuse, alcohol misuse, homelessness, or 
imprisonment)14, which is incongruent with the higher overall 
rates of deprivation in foreign-born compared with UK-born 
populations32.
Conclusions
It is a common misconception that migrants have a higher 
incidence of TB disease compared with the general population 
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simply because they ‘import’ it from abroad. Bakhshi suggests 
that they “present a tuberculosis picture from the country of ori-
gin and not the United Kingdom where the disease eventually 
manifests”29. Indeed, differential pathogen exposure can explain 
much of the higher incidence of TB among migrants and 
ethnic minorities, due to both pre-migration residence in high- 
incidence countries and maintenance of transnational links with 
the country of birth or ethnic origin. However, positing this as 
the sole driver fails to address the complex interplay of factors 
driving the vulnerability of particular migrant and ethnic groups 
to infection and progression to active disease. These include 
genetic susceptibility, vitamin D deficiency due to climatic and 
dietary factors, co-morbidities including DM, HIV and CKD, 
socio-economic deprivation, and factors linked to the experience 
of migration itself. Furthermore, certain migrant and ethnic 
groups face barriers to accessing treatment including cultural 
differences in treatment-seeking behaviours, stigmatisation of 
sufferers, and barriers to healthcare access. As stated by Offer 
et al., “TB in ethnic minorities does not occur in isolation but 
against a backdrop of socioeconomic, political and cultural 
context that affects their knowledge, attitudes and 
behaviours”169. The resultant delays in diagnosis and treatment 
lead to increased transmission and incidence in these 
communities.
In this way, there are factors disadvantaging migrants and 
ethnic minorities at each stage of the disease, relating to risk of 
pathogen exposure, vulnerability to infection, development of 
active disease, and access to treatment. Although heteroge-
neity between and within broad migrant and ethnic groups 
leads to variation in risk at each of these stages, there is a net 
effect of higher incidence among migrants and ethnic minorities 
compared with the general UK population. It is important to 
understand the complex and multifactorial drivers of this disparity 
in order to implement effective policies for tackling TB in 
these vulnerable groups. Currently, migrants from countries 
with high TB incidences are screened for active TB before 
entry to the UK. However, to complement such measures, which 
only consider the driver of differential pathogen exposure, more 
consideration is needed regarding policies that address the 
factors making migrants and ethnic minorities more vulnerable 
to reactivation of LTBI following their arrival in the UK. This 
might include vitamin D supplementation, measures targeting 
co-morbidities, and policies that promote socio-economic equity 
and migrant rights. In order to reduce delays in diagnosis and 
treatment, and thereby minimise transmission within migrant 
and ethnic minority communities, increased health education on 
TB causation, risk and transmission is required, as well as 
tackling stigmatisation of vulnerable groups. It is also important 
to raise awareness of migrants’ entitlement to diagnosis and 
treatment through the NHS, alongside reducing cultural and 
economic barriers to its access.
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ethnicity and socio-economic status, it is hard to disentangle the extent to which socio-economic
disadvantage influences TB incidence in migrant and ethnic minority populations" - I suggest this needs to
be more explicit from the start and particularly as you risk, perhaps (my reading of it) conflating the
migrant and ethnic-minority experience thus contributing to an idea that non-white = non British.
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 relation to race and racism, for example, chapters 1 and 2 (the rise and fall of race) in Discovering TB by
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conditions...." - Please can you delete 'erroneously': You previously discuss vitamin D and migration -
both related to 'climate conditions' as possible risk factors for TB (I realise this is not necessarily what the
participants were getting at in their interviews but still think best to remove it) My other reason for
removing it is that it undermines what is ''truth' as experienced by patients.  
- 'Non-compliance' - I tend to use adherance as per NICE
guidelines https://www.nice.org.uk/guidance/cg76
- "Farmer criticises anthropological investigations for conflating structural violence with cultural difference"
- The report the 'snowy white peaks of the NHS' and the McPherson report in the wake of the Stephen
Lawrence inquiry talked about institutional racism within the NHS and I wonder whether this would be
useful to mention as you talk about cultural barriers in relation to language, knowledge of health systems
etc but, although you mention 'racial' barriers it is within the context of talking about migrants, rather than
British-born BAME communities whose challenges in accessing care you don't specifically address.
Is the topic of the review discussed comprehensively in the context of the current literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
 I am part of two groups that campaign for healthcare access rights for migrants:Competing Interests:
Medact Refugee Solidarity Group and Docs Not Cops. I have no pecuniary interests relating to this.
Reviewer Expertise: Healthcare access, tuberculosis, migration, qualitative research, social science
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
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